latest news releases from the newsroom
Infinity Pharmaceuticals, Inc.
Infinity to Present At Piper Jaffray 20th Annual Health Care Conference
CAMBRIDGE, Mass., Nov. 26, 2008 (GLOBE NEWSWIRE) -- Infinity Pharmaceuticals, Inc. (Nasdaq:INFI), an innovative cancer drug discovery and development company, today announced that Adelene Q. Perkins, president & chief business officer, will be presenting a company overview at the Piper Jaffray 20th Annual Health Care Conference in New York. Infinity's presentation will take place on December 3, 2008 at 4:00 p.m. EST.
Investors of Medicis Pharmaceutical Corporation are Reminded by the Pomerantz Law Firm of Tuesday Lead Plaintiff Deadline -- MRX
NEW YORK, Nov. 26, 2008 (GLOBE NEWSWIRE) -- Pomerantz Haudek Block Grossman & Gross LLP ("Pomerantz" or the "Firm") remind investors of Medicis Pharmaceutical Corporation ("Medicis" or the "Company") (NYSE:MRX) that December 2 is the deadline to request that the Court appoint you as Lead Plaintiff in the class action. Pomerantz filed an action against the company (2:08-cv-01821-GMS) and certain officers of the Company on behalf of purchasers of Medicis' common stock during the period from October 30, 2003 to September 23, 2008, both dates inclusive, (the "Class Period"). The lawsuit was filed in the United States District Court, District of Arizona for violations of Sections 10(b) and 20(a) of the Securities Exchange Act of 1934.
Sadia S.A. Sued for Securities Violations by Pomerantz Haudek Block Grossman & Gross LLP -- SDA, SDIA3
NEW YORK, Nov. 26, 2008 (GLOBE NEWSWIRE) -- Pomerantz Haudek Block Grossman & Gross LLP (www.pomerantzlaw.com) ("Pomerantz") has filed a class action lawsuit in the United States District Court, Southern District of New York, against Sadia S.A. ("Sadia" or the "Company") (NYSE:SDA) (Sao Paolo:SDIA3.SA) and certain officers of the company. The complaint alleges violations of Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the SEC. The class action, captioned Radzik v. Sadia S.A. et al., Civil Action No. 08-CV-9930 (S.D.N.Y.), was filed on behalf of those investors who purchased the Company's American Depository Receipts ("ADRs") between April 30, 2008 and September 26, 2008 ("Class Period").
LTX-Credence Corporation Announces First Quarter Earnings Release and Conference Call
MILPITAS, Calif., Nov. 26, 2008 (GLOBE NEWSWIRE) -- LTX-Credence Corporation (Nasdaq:LTXC), a global provider of focused, cost-optimized ATE solutions, today announced the Company will release financial results for its first quarter, ended October 31, 2008, on Tuesday, December 9, 2008 after the market closes. A conference call will follow at 4:30 p.m. EST to discuss the Company's first quarter fiscal 2009 financial results and second quarter fiscal 2009 guidance.